Found 11 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases N/A The goal of this observational study is to extract the imaging features of ...
Show More Location
Shanghai Cancer center
Learn More & Join Trial
Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study) PHASE2 * In this study, we hypothesized that immune engagement by amivantamab will...
Show More Location
Multiple Locations
Learn More & Join Trial
Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. PHASE2 Pemetrexed is one of the first-line chemotherapeutic agents for non-squamou...
Show More Location
The Affiliated Huizhou Hospital, Guangzhou Medical University
Learn More & Join Trial
EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC PHASE2 This study is an open-label, multicenter, single-arm clinical study....
Location
Southern Medical University Nanfang Hospital Department of Oncology
Learn More & Join Trial
Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer PHASE1 This phase I trial studies the side effects and best dose of afatinib and n...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Therapy for Advanced NSCLC With EGFR 19delins Mutation EARLY_PHASE1 In a retrospective analysis of 3,054 advanced NSCLC patients, 41 with EGFR ...
Show More Location
Multiple Locations
Learn More & Join Trial
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) N/A Lung cancer is currently the world's largest malignant tumor for cancer-rel...
Show More Location
Department of Oncology, The Second Xiangya Hospital, Central South University
Learn More & Join Trial
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study N/A This study is a prospective, multicenter, real-world study to investigate t...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC:Retrospective Study N/A This is a nationwide, multicenter and retrospective cohort study. The purpo...
Show More Location
Affiliated Hospital of Nantong University
Learn More & Join Trial